| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 155,187 | 143,375 | 163,825 | 177,971 | | Cost of Revenue | 105,235 | 93,582 | 107,049 | 109,995 | | | Gross Profit | 49,952 | 49,793 | 56,776 | 67,976 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,208 | 37,398 | 35,941 | 41,582 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,744 | 12,395 | 20,835 | 26,394 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 14,744 | 12,395 | 20,835 | 26,394 | | Interest Expense | 140 | 99 | 90 | 53 | | Income Before Tax | 14,604 | 12,296 | 20,745 | 26,341 | | Income Tax Expense | 1,537 | 1,628 | 5,290 | 8,957 | | Minority Interest | (260) | (382) | (392) | (176) | | | | Net Income From Continuing Ops | 12,807 | 10,286 | 15,063 | 17,208 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,807 | 10,286 | 15,063 | 17,208 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,807 | $10,286 | $15,063 | $17,208 |
|
0.02% Nasdaq 
Income Statement
